Effectiveness of a Structured Information interview in people with newly-diagnosed Multiple Sclerosis

ISRCTN	ISRCTN81072971
DOI	https://doi.org/10.1186/ISRCTN81072971
Protocol serial number	2007/R/19
Sponsor	Neurological Institute "C. Besta" Foundation IRCCS (Italy)
Funder	The Italian Multiple Sclerosis Society (Italy)

Submission date: 31/03/2008
Registration date: 30/04/2008
Last edited: 07/10/2014

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Nervous System Diseases

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Alessandra Solari
Scientific

Unit of Neuroepidemiology
Foundation IRCCS Neurological Institute C.Besta
Via Celoria, 11
Milan
20133
Italy

Phone	+39 (0)2 2394 2391
Email	solari@istituto-besta.it

Study information

Primary study design	Interventional
Study design	Multi-centre randomised controlled trial
Secondary study design	Randomised controlled trial
Study type	Participant information sheet
Scientific title
Study acronym	SIMS-Trial
Study objectives	To assess the effectiveness, in terms of patient knowledge and satisfaction with the information received, of a structured add-on information interview, given within 15 days of communicating a diagnosis of multiple sclerosis (MS).
Ethics approval(s)	Neurological Institute "C. Besta" Foundation IRCCS Ethics Committee, 18/12/2007, ref: 9/2007
Health condition(s) or problem(s) studied	Multiple sclerosis (MS)
Intervention	At least 120 patients will be recruited from eight Italian centres and randomly assigned to receive the study intervention (add-on information aids, n = 60) or control (no add-on information aids, n = 60). The add-on interview is conducted by trained neurologists (approximately one hour in length), during which information about MS is presented with the aid of a specifically designed compact disc (CD). The information is tailored to individual needs; the patient is also given a booklet containing all the information provided. The "Sapere Migliora" CD: "Sapere Migliora" can be approximately rendered as "knowledge helps"; it works in Italian because the initials of the condition are SM sclerosi multipla. The CD contains an introduction followed by a menu of the headings: 1. MS insights: 1.1. Central nervous system 1.2. The myelin and the axon 1.3. Myelin and axon's damage 1.4. Mechanisms of damage 2. The diagnosis: 2.1. Relapses 2.2. Most common symptoms at disease onset 2.3. Clinical examination 2.4. Laboratory examinations 3. What happens after diagnosis: 3.1. MS course 3.2. Scheduled visits 4. Therapies: 4.1. Research at basis of therapies 4.2. Treatment for relapses 4.3. Disease-modifying drugs 5. Emotions: 5.1. Common emotional reactions 5.2. Reactions due to neurological damage 5.3. Depression 6. Having a child: 6.1. Motherhood 6.2. Fatherhood 7. Frequently asked questions (FAQs): 7.1. General questions 7.2. Questions on pregnancy 8. Glossary Animations and intuitively-obvious aids are used extensively throughout the CD. A voice in the background illustrates the entire presentation. Emotions are also presented as a movie lasting eight minutes. At the beginning of the interview, the "Sapere Migliora" CD is started and an opening menu appears. The patient indicates to the "informing neurologist" at which point on the program he/she wants to start. The "informing neurologist" navigates through the program guided by the patient's preferences, spending as much time as needed on each topic, skipping parts that the patient shows little interest in; opportunity is provided to repeat the exposition of topics and discuss them. Links to the glossary are present from all pertinent points on the program. Patients are encouraged to ask questions. The path through the CD during the session is traced electronically, and time spent on each topic is recorded, for subsequent analysis. At the end of the interview the patient is given the take-home booklet. At each centre there will be an "informing neurologist" trained to conduct the add-on interview. It is desirable that the referring neurologist is always the same for each patient; however, in large centres working in a team a single patient can be followed by more than one referring physician. The "Sapere Migliora" Booklet: The "Sapere Migliora" take-home booklet (A5 148 x 210 mm notepad format) has eight chapters (90 pages), a glossary (36 pages), and a section for the patient's notes. The first seven chapters match the CD topics in title and information provided. Chapter eight (Communicating the MS diagnosis: experiences of patients and health professionals) reports findings from our preliminary study. At the end of each chapter a small number of references/links are given, selected from the most comprehensive and up-to-date material available, many in Italian but some in English. Total duration of follow-up: six months.
Intervention type	Other
Primary outcome measure(s)	Primary endpoints, assessed one and six months after diagnosis disclosure, are knowledge and satisfaction with diagnosis communication as determined by the MS Knowledge Questionnaire (MSKQ) and the instrument "Comunicazione medico-paziente nella Sclerosi Multipla" (revised) (CoSM-R): 1. MSKQ: no widely-accepted measure of patient knowledge on MS is currently available. The MSKQ, specifically devised for this study, consists of 25 multiple-choice items, is self-administered, and designed to be applicable to a wide range of people with MS. The total score is the number of correct responses (range 0 - 25). 2. CoSM-R: this MS-specific scale was recently devised for this study. CoSM-R is self-administered and consists of multiple-choice questions about the moment of MS diagnosis communication (9 items), and about the period immediately following diagnosis communication (16 items).
Key secondary outcome measure(s)	Secondary endpoints are changes at one and six months in: 1. The Hospital Anxiety and Depression Scale (HADS) 2. The Control Preference Scale (CPS). The CPS was translated and cross-culturally adapted into Italian from the original English version. Other endpoints measured over the study period: 3. Attrition 4. Number of consultations 5. Number of visits to the MS centre
Completion date	31/03/2010

Eligibility

Participant type(s)	Patient
Age group	Adult
Lower age limit	18 Years
Sex	All
Target sample size at registration	120
Key inclusion criteria	Subjects are eligible for recruitment if all the following criteria are satisfied: 1. Diagnostic workup to confirm/exclude MS diagnosis 2. Age 18 years and above, either sex 3. Signed informed consent (pre-diagnostically) Consenting subjects will be randomised at the end of the diagnostic workup, provided that all the following criteria apply: 1. Diagnosis of MS confirmed 2. Interval between informed consent and MS diagnosis within seven months
Key exclusion criteria	Subjects will be excluded from the study if one or more of the following criteria apply: 1. Previous MS diagnosis 2. Presence of definite cognitive compromise, psychiatric disease, or substance abuse
Date of first enrolment	18/03/2008
Date of final enrolment	31/03/2010

Locations

Countries of recruitment

Italy

Study participating centre

Unit of Neuroepidemiology

Milan
20133
Italy

Results and Publications

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/11/2010		Yes	No
Results article	results	15/08/2011		Yes	No
Results article	qualitative study results	01/02/2014		Yes	No
Results article	results	01/02/2014		Yes	No
Participant information sheet	Participant information sheet	11/11/2025	11/11/2025	No	Yes